supplementary material – Page 38 – Communicable Diseases Research

The Impact of COVID-19 on Routine Medical Care and Cancer Screening

일상적인 의료 및 암 검진에 대한 COVID-19의 영향

Original Research

Published on 2022-01-102022-09-10
Journal: Journal of General Internal Medicine [Category] COVID19(2023년), MERS, SARS, 치료기술,

Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study

Research

Published on 2022-01-102022-11-01
Journal: Critical Care [Category] COVID-19, SARS,

[키워드] 95% CI adjusted hazard ratio affected age Analysis ARDS association chest CT scan Cohort COVID-19 critical COVID-19 patient Critically ill patient critically ill patients delay in intubation Early intubation evaluated Follow-up greater hospital hospital discharge Impact IMV in-hospital mortality increase in Intubated intubation Invasive mechanical ventilation lobe male material mean difference median Mortality Patient Prospective prospective cohort study pulmonary sequelae receiving required respiratory management Respiratory Support Result risk significant increase supplementary material survival TSS with COVID-19
[DOI] 10.1186/s13054-021-03882-1 PMC 바로가기 [Article Type] Research

Impact of the COVID-19 pandemic’s first wave on the care and treatment situation of intravitreal injections in a German metropolitan region

COVID-19 대유행의 첫 번째 물결이 독일 대도시 지역의 유리체강내 주사 치료 및 치료 상황에 미치는 영향

Retinal Disorders

Published on 2022-01-102022-09-12
Journal: Graefe's Archive for Clinical and Experimental Oph [Category] COVID19(2023년), MERS, SARS, 진단,

Healthcare institutions’ recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study

의료 종사자 간의 FFP-2 마스크 사용 및 SARS-COV-2 혈청 양성 사용에 관한 의료 기관의 권고 : 다기관 종단 코호트 연구

Multicenter Study

Published on 2022-01-102022-09-01
Journal: Antimicrobial Resistance and Infection Control [Category] 진단, 치료기술,

[키워드] 95% CI analyzed association baseline Care chemiluminescence immunoassay contact with COVID-19 COVID-19 incidence COVID-19 patient COVID-19 patients Effect evaluated exposure to Face mask Face masks FFP-2 and surgical masks Follow-up HCW HCWs Health Health care healthcare Healthcare workers immunoassay incidence Local longitudinal cohort study Mask Mask policy Masks multicenter multivariable analyses multivariable analysis multivariable logistic regression not affect pandemic participant Probability questionnaire recruited Result risk factor Risk factors Roche Diagnostics SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 infected individual SARS-CoV-2 infected individuals SARS-COV-2 infection sera Seroconversion seroconversion rate seroconversion rates Significant supplementary material surgical Switzerland the strongest univariable
[DOI] 10.1186/s13756-021-01047-x PMC 바로가기 [Article Type] Multicenter Study

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses

MEK1/2 억제제 ATR-002는 SARS-CoV-2 전파를 효율적으로 차단하고 전염증성 사이토카인/케모카인 반응을 완화합니다

Original Article

Published on 2022-01-102022-09-10
Journal: Cellular and Molecular Life Sciences [Category] 치료제,

[키워드] accelerated activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 alleviate anti-influenza drug Anti-SARS-CoV-2 Activity antiviral drug ATR-002 block cascade caused Cell Cell culture cell line cell lines clinical trial clinical trials coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 progression cultures Cytokines death Disease progression Drug evaluation early infection epithelial epithelial cell evaluated expression fibrosarcoma high-risk patient High-risk patients hyperinflammation impair Infection inhibitor kinase kinases knockdown limit medication MEK1/2-inhibitor mitogen mitogen-activated protein kinase Novel coronavirus observé pandemic pandemic spread pathway powerful tool Prevent pro-inflammatory pro-inflammatory cytokines Protein Raf/MEK/ERK respiratory response Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 propagation selective severe acute respiratory syndrome Coronavirus Signaling specific inhibitor Spread supplementary material Symptom target therapeutic intervention Treatment upstream vaccination virus replication while
[DOI] 10.1007/s00018-021-04085-1 PMC 바로가기 [Article Type] Original Article

Time trends in mental health indicators during the initial 16 months of the COVID-19 pandemic in Denmark

Research

Published on 2022-01-102022-10-27
Journal: BMC Psychiatry [Category] Coronavirus, SARS,

[키워드] affected age analysed Anxiety asked changes in Chronic illness collected Comparisons Course COVID-19 COVID-19 pandemic cross-sectional defined demonstrated Denmark Deterioration diagnosed estimate examined Factor Follow-up Gender group independent individual individuals initial less lockdown lockdowns loneliness longitudinal Mental mental health mental illness National occurred outcome pandemic proportions Prospective Quality of life questionnaire reactive repeated reported respond Result resulting social isolation Study design subgroup subgroups supplementary material time Time-series timepoint timepoints trend were used worries
[DOI] 10.1186/s12888-021-03655-8 PMC 바로가기 [Article Type] Research

Field epidemiology training programs contribute to COVID-19 preparedness and response globally

Research

Published on 2022-01-102022-10-28
Journal: BMC Public Health [Category] Coronavirus, SARS,

[키워드] activities activity Analysis Community conducted contribute contributed contributing to country COVID-19 Critical cross-sectional survey description effort eight ENhance epidemiological epidemiologist Epidemiology FETP field Field epidemiology global health global health security Guidance help indicated International Health Regulations Pandemic response pillar plan provide public health public health emergency public health threat qualitative data Quantitative rapid response regions response Result risk Seven supplementary material Surveillance Threats WHO WHO’ World Health Organization’
[DOI] 10.1186/s12889-021-12422-z PMC 바로가기 [Article Type] Research

SARS-CoV-2 in pediatric cancer: a systematic review

Review

Published on 2022-01-102022-10-31
Journal: European journal of pediatrics [Category] COVID-19, COVID19(2023년), SARS,

[키워드] acute respiratory syndrome analyzed Asymptomatic Cancer cancer patient Cancer patients cancer treatment Chemotherapy children Clinical course cohort study Comorbidities Complication conducted coronavirus Course COVID-19 COVID-19 infections current database died Evidence exploratory Hospitalized identify infected with SARS-CoV-2 Infection information International literature review malignancy malignant disease Mild moderate Modification morbidity Mortality MOST oncologist outbreak outcome pandemic Patient patients patients with SARS-CoV-2 pediatric Pediatric patient reported review risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positivity severe COVID-19 severe COVID-19 disease supplementary material systematic literature search systematic review weighed Wuhan
[DOI] 10.1007/s00431-021-04338-y PMC 바로가기 [Article Type] Review

Identification of the role of oral health educators in elementary schools during COVID-19 pandemic: a competency framework

Research Note

Published on 2022-01-102022-10-27
Journal: BMC Research Notes [Category] Coronavirus, SARS,

SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey

레바논의 SARS-COV-2 항체 혈청 유병률 : 최초의 전국 세로비의 발견

Research

Published on 2022-01-102022-09-01
Journal: BMC Infectious Diseases [Category] SARS, 진단, 치료기술,

[키워드] 95% CI affected age anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody Blood conducted confirmed cases conjunction country COVID-19 COVID-19 case COVID-19 cases COVID-19 pandemic cumulative detect effective estimate evaluate General population group herd immunity IgG IgM Immunity Immunoglobulin Immunoglobulin G individual laboratory-confirmed Lebanon Middle East National P-value pandemic Participants POCT point-of-care positive Prevalence preventive measure preventive measures Rapid test Registered reported residence Result resulting SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection Seroprevalence Serosurvey Sex significant difference significant differences Spread spreads subject supplementary material Surveillance susceptible the epidemic vaccination virus was used weighed Weighting
[DOI] 10.1186/s12879-022-07031-z PMC 바로가기 [Article Type] Research